Seeing Is Believing
Currently out of the existing stock ratings of Ekaterina Knyazkova, 2 are a HOLD (25%), 6 are a BUY (75%).
Analyst Ekaterina Knyazkova, currently employed at JPMORGAN, carries an average stock price target met ratio of 61.11% that have a potential upside of 23.73% achieved within 100 days.
Ekaterina Knyazkova’s has documented 16 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PAHC, Phibro Animal Health at 07-Nov-2025.
Analyst best performing recommendations are on PAHC (PHIBRO ANIMAL HEALTH).
The best stock recommendation documented was for PAHC (PHIBRO ANIMAL HEALTH) at 9/10/2024. The price target of $22 was fulfilled within 20 days with a profit of $1.6 (7.84%) receiving and performance score of 3.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 26-Aug-2025
$20
$0.06 (0.30%)
1 months 6 days ago
(29-Jun-2026)
2/3 (66.67%)
$-0.71 (-3.43%)
26
Hold Since 08-Apr-2026
$20
$0.06 (0.30%)
$23
2 months 1 days ago
(03-Jun-2026)
4/7 (57.14%)
$1.88 (10.38%)
61
Buy Since 22-Nov-2024
$19
$-0.94 (-4.71%)
$35
2 months 21 days ago
(14-May-2026)
1/3 (33.33%)
$1.7 (9.83%)
13
Hold Since 21-Mar-2025
$21
$1.06 (5.32%)
$25
2 months 24 days ago
(11-May-2026)
12/19 (63.16%)
$2.55 (13.82%)
285
Buy Since 22-Oct-2025
$30
2 months 27 days ago
(08-May-2026)
9/13 (69.23%)
$9.77 (48.29%)
299
What Year was the first public recommendation made by Ekaterina Knyazkova?